Inhibition of the PLK1‐Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer

Abstract Dysregulation of the cell cycle machinery leads to genomic instability and is a hallmark of cancer associated with chemoresistance and poor prognosis in colorectal cancer (CRC). Identifying and targeting aberrant cell cycle machinery is expected to improve current therapies for CRC patients...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zhaoliang Yu, Peng Deng, Yufeng Chen, Shini Liu, Jinghong Chen, Zihuan Yang, Jianfeng Chen, Xinjuan Fan, Peili Wang, Zerong Cai, Yali Wang, Peishan Hu, Dezheng Lin, Rong Xiao, Yifeng Zou, Yan Huang, Qiang Yu, Ping Lan, Jing Tan, Xiaojian Wu
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2021-12-01
Col·lecció:	Advanced Science
Matèries:	cell division cycle 7 colorectal cancer MYC oxaliplatin polo‐like kinase 1
Accés en línia:	https://doi.org/10.1002/advs.202100759
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!